Overcome drug resistance in your preclinical research with our diverse models, including patient-derived xenografts (PDX). Use our oncology databases to find the most relevant models and access extensive profiling and pharmacologic data. Enhance your research with advanced biomarker analysis, multi-omics, spatial biology assays, and data science platforms, driving effective drug discovery.
Our unique four-step approach offers personalized strategies to address various drug resistance challenges, facilitating the successful acceleration of your project. By analyzing intrinsic and acquired resistance across diverse therapeutic types and molecular targets, we craft tailored solutions that enhance treatment efficacy.
Navigate the complexities of drug resistance using our strategic solutions and robust resources, designed to accelerate your drug development journey, ensuring you achieve success with greater efficiency.
Our customized integrated solutions provide you with a comprehensive suite of resistance models across in vitro, in vivo, ex vivo, and in silico platforms, supported by a living biobank of over 30 cancer types. Our ongoing R&D efforts continually expand our catalog, and we offer custom model development to meet specific research needs. By integrating biomarker strategies, we help predict clinical responses, enabling the identification of translatable solutions and accelerating research progress.
Studies
Completed
This data point indicates the total number of studies in Q2 2023 that the CSAT, Customer Effort, and Customer Expectation scores are measured against.
Studies
Completed
Customer
Satisfaction
Also known as CSAT, this metric indicates how satisfied customers are with the complete Crown Bioscience customer experience.
Customer
Satisfaction
Customer
Effort
The Customer Effort Score (CES) is a metric that measures how easy it was to work with Crown Bioscience.
Customer
Effort
